14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 CPRX stock ended at $15.14. This is 1.00% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 2.97% from a day low at $14.82 to a day high of $15.26.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
Feb 27, 2023 $15.35 $15.57 $15.25 $15.38 1 383 020
Feb 24, 2023 $15.22 $15.57 $15.11 $15.26 1 099 756
Feb 23, 2023 $15.47 $15.49 $15.15 $15.28 1 702 738
Feb 22, 2023 $15.31 $15.46 $15.19 $15.38 1 237 936
Feb 21, 2023 $15.47 $15.54 $15.21 $15.25 2 229 715
Feb 17, 2023 $15.26 $15.69 $15.04 $15.52 2 274 125
Feb 16, 2023 $15.21 $15.39 $15.00 $15.21 1 359 790
Feb 15, 2023 $15.41 $15.50 $15.21 $15.36 1 910 477
Feb 14, 2023 $15.51 $15.57 $15.24 $15.46 1 092 255
Feb 13, 2023 $15.49 $15.75 $15.23 $15.54 1 243 842
Feb 10, 2023 $15.50 $15.62 $15.23 $15.47 915 850
Feb 09, 2023 $15.46 $15.70 $15.37 $15.48 1 164 367
Feb 08, 2023 $16.21 $16.41 $15.24 $15.30 1 703 457
Feb 07, 2023 $16.01 $16.24 $15.73 $16.21 2 271 162
Feb 06, 2023 $16.13 $16.50 $15.75 $15.87 1 588 536
Feb 03, 2023 $15.72 $16.22 $15.72 $16.10 1 690 721
Feb 02, 2023 $15.25 $15.92 $15.11 $15.80 2 781 391
Feb 01, 2023 $15.59 $15.59 $14.86 $15.31 2 648 082
Jan 31, 2023 $15.75 $15.96 $15.25 $15.49 2 313 597
Jan 30, 2023 $15.35 $16.10 $15.31 $15.72 2 340 612
Jan 27, 2023 $16.00 $16.45 $15.45 $15.52 2 938 583
Jan 26, 2023 $16.98 $16.98 $15.87 $15.99 2 905 014
Jan 25, 2023 $15.70 $16.88 $15.53 $16.73 3 762 454
Jan 24, 2023 $14.79 $16.25 $14.71 $16.12 5 906 344
Jan 23, 2023 $18.32 $18.41 $13.30 $14.76 18 418 325
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT